Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
9.01
-0.41 (-4.35%)
At close: Oct 17, 2025, 3:59 PM
9.01
0.00%
After-hours: Oct 17, 2025, 04:31 PM EDT
Cartesian Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 38.91M | 26M | 110.78M | 85.08M |
Cost of Revenue | n/a | 1.55M | 2.04M | n/a |
Gross Profit | 38.91M | 24.45M | 108.74M | 85.08M |
Operating Income | -43.9M | -86.42M | 14.54M | -4.6M |
Interest Income | 7.39M | 4.96M | n/a | n/a |
Pretax Income | -77.14M | -238.71M | 34.77M | -9.72M |
Net Income | -77.42M | -219.71M | 35.38M | -25.69M |
Selling & General & Admin | 30.13M | 39.03M | 23.86M | 20.94M |
Research & Development | 45.1M | 71.84M | 72.38M | 68.74M |
Other Expenses | 7.58M | n/a | -2.04M | n/a |
Operating Expenses | 82.81M | 110.87M | 94.2M | 89.67M |
Interest Expense | n/a | 2.83M | 3.03M | 2.84M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 82.81M | 112.42M | 96.24M | 89.67M |
Income Tax Expense | 287K | -19M | -609K | 15.97M |
Shares Outstanding (Basic) | 25.91M | 5.17M | 4.02M | 3.18M |
Shares Outstanding (Diluted) | 155.11M | 5.17M | 4.05M | 3.18M |
EPS (Basic) | -2.99 | -49.76 | 7.33 | -6.74 |
EPS (Diluted) | -0.5 | -49.76 | 3.00 | -6.6 |
EBITDA | -77.14M | -235.06M | 39.84M | -5.16M |
EBIT | -77.14M | -235.88M | 37.8M | -6.88M |
Depreciation & Amortization | 1.15M | 843K | 2.04M | 1.72M |
Source: Financial Modeling Prep. Financial Sources.